MERRIMACK PHARMACEUTICALS INC Debt Conversion, Original Debt, Amount
MERRIMACK PHARMACEUTICALS INC reported Debt Conversion, Original Debt, Amount of $64.21 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2018-03-12
- MERRIMACK PHARMACEUTICALS INC debt conversion, original debt, amount for the quarter ending 2016-12-31 was $0.00.
- MERRIMACK PHARMACEUTICALS INC debt conversion, original debt, amount for the quarter ending 2016-09-30 was $0.00.
- MERRIMACK PHARMACEUTICALS INC debt conversion, original debt, amount for fiscal 2016 was $64.21M.
- MERRIMACK PHARMACEUTICALS INC debt conversion, original debt, amount for fiscal 2014 was $1.04M, a 59.89% decline from fiscal 2013.
- MERRIMACK PHARMACEUTICALS INC debt conversion, original debt, amount for fiscal 2013 was $2.60M.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-03-12 | $64.21M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $64.21M 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $64.21M 10-Q · filed 2016-08-04 | |||
| 2014-12-31 | $1.04M 10-K · filed 2016-02-26 | |||
| 2013-12-31 | $2.60M 10-K · filed 2016-02-26 |